Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Irina Vasilyeva Anatolievna (Moscow, Russian Federation), Irina Vasilyeva, Anastasia Samoilova, Marina Burakova, Tatev Bagdasaryan, Elena Larionova, Larisa Chernousova. Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy. Eur Respir J 2015; 46: Suppl. 59, 1525

Member's Comments

No comment yet.

Related content which might interest you: Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Gene-Xpert for rapid detection of MDR-TB in re-treatment cases;a comparison with standard culture and DST Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 MDR-TB treatment outcomes in HIV positive patients Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Tuberculosis diagnosis in rural Namibia using gene Xpert MTB/RIF testing Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 Estimation of the role of the test GeneXpert MTB-RIF in the diagnosis of pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Rifampicin-resistant TB on Gene Xpert: What is the best empiric combination treatment while awaiting cultures? Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Detection of TB by smear microscopy and GeneXpert MTB/RIF assay in non expectorating pulmonary TB suspects and pleural TB in high prevalent low income setting Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014 Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 MOTT as a cause of treatment failure in pulmonary tuberculosis Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Prospects for early implementation of ambulatory treatment in XDR TB patients by optimizing the administration of linezolid at the intensive phase of chemotherapy Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 MDR-TB guidelines: what is new on clinical management Source: ERS Webinar 2020: MDR-TB guidelines: what is new on clinical management Year: 2020 Determining the role of Xpert® MTB/RIF in diagnosing tuberculosis in postmortem tissues Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Linezolid in the treatment of patients with MDR TB and XDR TB Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Xpert MTB/RIF testing of pooled induced sputum Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014 Clinical profile of MDR-TB patients and their early response to DOTS PLUS: An Indian perspective Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 Bedaquiline-containing regimens for MDR TB treatment – Focus on the safety Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016